NEW YORK (Reuters Health) - Acute stomach infections may increase the risk of developing inflammatory bowel disease such as ulcerative colitis or Crohn's disease, investigators report.
NEW YORK, Nov. 6 (UPI) -- U.S. medical scientists say they've determined chronic inflammation can cause stomach cancer -- the second leading cause of cancer deaths in the world.
ORLANDO, Fla., Oct. 8 (UPI) -- Probiotics ease symptoms and help normalize bowel movement frequency in patients with Irritable Bowel Syndrome, or IBS, U.S. researchers say.
LONDON, Oct. 7 (UPI) -- British medical scientists say they've made a series of "groundbreaking" discoveries that have major implications for the treatment of colon cancer.
WASHINGTON, Sept. 15 (UPI) -- The U.S. Food and Drug Administration approved an immune globulin product called Gamunex for treatment of chronic inflammatory demyelinating polyneuropathy.
AMSTERDAM, Netherlands, Sept. 9 (UPI) -- People with genital herpes, gonorrhea, syphilis and chlamydia have an increased risk of being infected if exposed to HIV, Dutch researchers warn.
ATLANTA, Aug. 21 (UPI) -- U.S. medical engineers say they have developed biodegradable polymers that might help improve treatment of acute inflammatory illnesses.
BOSTON, June 30 (UPI) -- A U.S.-led science team says it has identified 21 new genetic risk factors for Crohn's disease, bringing the total number of such risk sites to 32.
NEW YORK, June 2 (UPI) -- U.S. researchers now advise colon cancer screening before age 50 because adenomas -- pre-cancerous masses in the colon -- develop earlier than thought.
BOSTON, May 28 (UPI) -- U.S. medical scientists say they've discovered a sugar molecule produced by a bacterium in a person's gut that can mitigate colitis symptoms in lab animals.
WASHINGTON, May 21 (UPI) -- The U.S. Food and Drug Administration announced approval of the drug Entereg (alvimopan) to help restore normal bowel function after surgery.
URBANA, Ill., May 21 (UPI) -- University of Illinois researchers report a compound found in celery and green peppers can disrupt a component of the inflammatory response in the brain.
ST. LOUIS, May 19 (UPI) -- U.S. medical scientists have found a new type of immune response that might lead to improved treatment of people with chronic inflammatory lung disease.
WASHINGTON, April 28 (UPI) -- The U.S. Food and Drug Administration has approved Relistor (methylnaltrexone bromide) to help restore bowel function in patients receiving opioids.